Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2018-10-25 Earnings Release
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
FORM 8-K 3 pages 78.3KB
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text includes an Item 2.02 disclosure of results of operations for the quarter ended September 30, 2018, referencing a press release attached as Exhibit 99.1. It also includes an Item 8.01 announcement of a quarterly cash dividend declaration with record and payment dates. The document is 3770 characters long, which is relatively short and primarily serves as an announcement rather than a full financial report. The presence of a press release describing quarterly results and a dividend announcement aligns with typical content of an Earnings Release (ER) filing. The document does not contain full financial statements or detailed analysis, so it is not an Interim/Quarterly Report (IR). It is not a Report Publication Announcement (RPA) because it includes substantive information about the dividend and earnings results. Therefore, the best classification is Earnings Release (ER). Q1 2019
2018-10-25 English
ResMed Announces Results for the First Quarter of FY 2019 9 pages 385.4KB
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of financial results for the first quarter of fiscal year 2019 by ResMed Inc. It includes comprehensive financial data such as revenue, net income, earnings per share, operating expenses, and balance sheet information. The presence of detailed financial statements and analysis for a quarterly period indicates this is a quarterly financial report. The document also mentions it is unaudited and covers the three months ended September 30, 2018, which aligns with an Interim / Quarterly Report. It is not merely an earnings release since it contains substantive financial data and analysis, nor is it a short announcement or webcast notice. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2019
2018-10-25 English
Dividend/Distribution - RMD 4 pages 33.5KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related specifics. It is an announcement informing shareholders about the dividend payment rather than a full financial report or analysis. The content matches the description of a Notice of Dividend Amount filing, which announces dividend amounts and payment details to shareholders.
2018-10-25 English
Updated - RMD to Announce First Quarter Fiscal 2019 Results 1
Earnings Release Classification · 95% confidence The document is a short announcement from ResMed about the upcoming release of its first quarter fiscal 2019 earnings results. It provides details on the date and time of the earnings release and webcast but does not contain any actual financial data or detailed financial statements. The document length is only 2103 characters, which is quite short and consistent with an announcement rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Earnings Release (ER), as it is the initial announcement of quarterly financial results. Q1 2019
2018-10-24 English
ResMed to Announce First Quarter Fiscal 2019 Results 1
Report Publication Announcement Classification · 95% confidence The document is a short announcement from ResMed about the upcoming release of its first quarter fiscal 2019 earnings results. It specifies the date and time of the earnings release and webcast but does not contain any actual financial data or detailed results. The document length is only 2103 characters, which is quite short and consistent with an announcement rather than a full report. It invites investors to listen to the webcast and states when the press release will be issued. This fits the definition of an Earnings Release (ER) announcement, but since it does not contain the actual earnings data or highlights, it is more accurately classified as a Report Publication Announcement (RPA) because it announces the timing of the earnings report and webcast rather than presenting the earnings themselves.
2018-10-04 English
Notice of Annual General Meeting/Proxy Form 116 pages 1.1MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'SCHEDULE 14A' and is a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It includes detailed information about the annual stockholders meeting, proposals to be voted on, board of directors election, compensation discussion and analysis, and other governance-related information. The document is a definitive proxy statement, which is a material sent to shareholders to provide information and solicit votes for the annual meeting. It is not an annual report, earnings release, or other financial report. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI).
2018-10-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.